Trulieve Cannabis (NYSE:TRLV) CEO Sells $1,915,020.25 in Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 204,815 shares of Trulieve Cannabis stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $9.35, for a total transaction of $1,915,020.25. Following the completion of the transaction, the chief executive officer owned 2,693,724 shares of the company’s stock, valued at $25,186,319.40. This represents a 7.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Price Performance

Shares of TRLV stock opened at $8.53 on Thursday. Trulieve Cannabis Corp. has a 1 year low of $3.42 and a 1 year high of $13.28.

Analyst Ratings Changes

A number of analysts recently issued reports on TRLV shares. Weiss Ratings initiated coverage on Trulieve Cannabis in a research note on Tuesday, June 16th. They set a “sell (d-)” rating on the stock. Zacks Research upgraded Trulieve Cannabis to a “hold” rating in a research note on Thursday, June 18th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce”.

About Trulieve Cannabis

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.